These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

625 related articles for article (PubMed ID: 23720981)

  • 1. A randomized double-blind, placebo-controlled trial of zinc sulfate supplementation for alleviation of radiation-induced oral mucositis and pharyngitis in head and neck cancer patients.
    Sangthawan D; Phungrassami T; Sinkitjarurnchai W
    J Med Assoc Thai; 2013 Jan; 96(1):69-76. PubMed ID: 23720981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zinc sulfate in the prevention of radiation-induced oropharyngeal mucositis: a prospective, placebo-controlled, randomized study.
    Ertekin MV; Koç M; Karslioglu I; Sezen O
    Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):167-74. PubMed ID: 14697435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic effect of recombinant human epidermal growth factor (RhEGF) on mucositis in patients undergoing radiotherapy, with or without chemotherapy, for head and neck cancer: a double-blind placebo-controlled prospective phase 2 multi-institutional clinical trial.
    Wu HG; Song SY; Kim YS; Oh YT; Lee CG; Keum KC; Ahn YC; Lee SW
    Cancer; 2009 Aug; 115(16):3699-708. PubMed ID: 19514089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zinc supplementation to improve mucositis and dermatitis in patients after radiotherapy for head-and-neck cancers: a double-blind, randomized study.
    Lin LC; Que J; Lin LK; Lin FC
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):745-50. PubMed ID: 16751063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenylbutyrate mouthwash mitigates oral mucositis during radiotherapy or chemoradiotherapy in patients with head-and-neck cancer.
    Yen SH; Wang LW; Lin YH; Jen YM; Chung YL
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1463-70. PubMed ID: 21840136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of topical misoprostol to reduce radiation-induced mucositis: results of a randomized, double-blind, placebo-controlled trial.
    Veness MJ; Foroudi F; Gebski V; Timms I; Sathiyaseelan Y; Cakir B; Tiver KW
    Australas Radiol; 2006 Oct; 50(5):468-74. PubMed ID: 16981945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of concurrent granulocyte macrophage-colony stimulating factor on radiation-induced mucositis in head and neck cancer patients: a double-blind placebo-controlled prospective phase III study by Radiation Therapy Oncology Group 9901.
    Ryu JK; Swann S; LeVeque F; Scarantino CW; Johnson D; Chen A; Fortin A; Pollock J; Kim H; Ang KK
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):643-50. PubMed ID: 17293228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized double blind, placebo-controlled study of pilocarpine administered during head and neck irradiation to reduce xerostomia.
    Sangthawan D; Watthanaarpornchai S; Phungrassami T
    J Med Assoc Thai; 2001 Feb; 84(2):195-203. PubMed ID: 11336078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral mucositis prevention by low-level laser therapy in head-and-neck cancer patients undergoing concurrent chemoradiotherapy: a phase III randomized study.
    Gouvêa de Lima A; Villar RC; de Castro G; Antequera R; Gil E; Rosalmeida MC; Federico MH; Snitcovsky IM
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):270-5. PubMed ID: 21163585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzydamine for prophylaxis of radiation-induced oral mucositis in head and neck cancers: a double-blind placebo-controlled randomized clinical trial.
    Kazemian A; Kamian S; Aghili M; Hashemi FA; Haddad P
    Eur J Cancer Care (Engl); 2009 Mar; 18(2):174-8. PubMed ID: 19267733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II double-blind randomized study comparing oral aloe vera versus placebo to prevent radiation-related mucositis in patients with head-and-neck neoplasms.
    Su CK; Mehta V; Ravikumar L; Shah R; Pinto H; Halpern J; Koong A; Goffinet D; Le QT
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):171-7. PubMed ID: 15337553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the efficacy of zinc sulfate in the prevention of chemotherapy-induced mucositis: a double-blind randomized clinical trial.
    Arbabi-kalati F; Arbabi-kalati F; Deghatipour M; Ansari Moghadam A
    Arch Iran Med; 2012 Jul; 15(7):413-7. PubMed ID: 22724877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of phase III double-blind, placebo-controlled trial from the North Central Cancer Treatment Group (N01C4).
    Halyard MY; Jatoi A; Sloan JA; Bearden JD; Vora SA; Atherton PJ; Perez EA; Soori G; Zalduendo AC; Zhu A; Stella PJ; Loprinzi CL
    Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1318-22. PubMed ID: 17394940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relief of radiation-induced oral mucositis in head and neck cancer.
    Putwatana P; Sanmanowong P; Oonprasertpong L; Junda T; Pitiporn S; Narkwong L
    Cancer Nurs; 2009; 32(1):82-7. PubMed ID: 19104205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of zinc sulfate supplementation on cell-mediated immune response in head and neck cancer patients treated with radiation therapy.
    Sangthawan D; Phungrassami T; Sinkitjarurnchai W
    Nutr Cancer; 2015; 67(3):449-56. PubMed ID: 25803777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylaxis of radiation-associated mucositis in conventionally treated patients with head and neck cancer: a double-blind, phase III, randomized, controlled trial evaluating the clinical efficacy of an antimicrobial lozenge using a validated mucositis scoring system.
    El-Sayed S; Nabid A; Shelley W; Hay J; Balogh J; Gelinas M; MacKenzie R; Read N; Berthelet E; Lau H; Epstein J; Delvecchio P; Ganguly PK; Wong F; Burns P; Tu D; Pater J
    J Clin Oncol; 2002 Oct; 20(19):3956-63. PubMed ID: 12351592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of benzydamine oral rinse in prevention and management of radiation-induced oral mucositis: A double-blind placebo-controlled randomized clinical trial.
    Sheibani KM; Mafi AR; Moghaddam S; Taslimi F; Amiran A; Ameri A
    Asia Pac J Clin Oncol; 2015 Mar; 11(1):22-7. PubMed ID: 25471468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blinded, placebo-controlled trial on intravenous L-alanyl-L-glutamine in the incidence of oral mucositis following chemoradiotherapy in patients with head-and-neck cancer.
    Cerchietti LC; Navigante AH; Lutteral MA; Castro MA; Kirchuk R; Bonomi M; Cabalar ME; Roth B; Negretti G; Sheinker B; Uchima P
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1330-7. PubMed ID: 16765532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Palifermin decreases severe oral mucositis of patients undergoing postoperative radiochemotherapy for head and neck cancer: a randomized, placebo-controlled trial.
    Henke M; Alfonsi M; Foa P; Giralt J; Bardet E; Cerezo L; Salzwimmer M; Lizambri R; Emmerson L; Chen MG; Berger D
    J Clin Oncol; 2011 Jul; 29(20):2815-20. PubMed ID: 21670447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of zinc sulfate on prevention, incidence, and severity of mucositis in leukemia patients undergoing chemotherapy.
    Rambod M; Pasyar N; Ramzi M
    Eur J Oncol Nurs; 2018 Apr; 33():14-21. PubMed ID: 29551172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.